Andrea Kwa Singapore

Andrea Kwa is a leading expert in antimicrobial resistance, Deputy Director (Research & Innovation) Pharmacy at Singapore General Hospital, Associate Professor at Duke-NUS Medical School, Singapore. Her research bridges individualised antibiotics combination testing for drug-resistant bacterial infections to clinical service, therapeutic-drug monitoring, phage therapy implementation and AI-driven antibiotic stewardship to combat multidrug-resistant pathogens. With over 100 publications, she integrates real-world clinical insights from Asia into global solutions. Dr. Kwa champions innovative strategies—phage precision and digital solutions to transform infection management. Her work empowers next-generation clinicians, fostering responsible antibiotic use and advanced therapeutic alternatives worldwide.

Main Congress - Day 2

Time	Session

10:00am 11:10am	Symposium 1B Infection Prevention and Control (IPC) Emerging Technological / Innovations in Infection Control Assoc. Prof.Andrea Kwa Chairperson Singapore General HospitalSingapore Assoc. Prof.Thi Anh Thu Le Chairperson Viet Nam Infection Control SocietyVietnam Novel Materials used for IPC Improvement Real Learning in a Virtual World: Enhancing Infection Prevention and Control Training and Competency with Virtual Reality Dr.Erica Shenoy Speaker SHEA, Massachusetts General HospitalUnited States Protect PIVC: The ProP Trial: An Adaptive Randomised Controlled Trial of a Novel Antimicrobial Dressing for Peripheral Intravenous Catheters (PIVCs) Prof.Claire Rickard Speaker The University of QueenslandAustralia Q&A Conference Hall 1

Time

Session

10:00am

11:10am

Symposium 1B

Infection Prevention and Control (IPC) Emerging Technological / Innovations in Infection Control

Assoc. Prof.Andrea Kwa Chairperson Singapore General HospitalSingapore

Assoc. Prof.Thi Anh Thu Le Chairperson Viet Nam Infection Control SocietyVietnam

Novel Materials used for IPC Improvement
Real Learning in a Virtual World: Enhancing Infection Prevention and Control Training and Competency with Virtual Reality

Dr.Erica Shenoy Speaker SHEA, Massachusetts General HospitalUnited States
Protect PIVC: The ProP Trial: An Adaptive Randomised Controlled Trial of a Novel Antimicrobial Dressing for Peripheral Intravenous Catheters (PIVCs)

Prof.Claire Rickard Speaker The University of QueenslandAustralia
Q&A

Conference Hall 1

Main Congress - Day 3

Time	Session

10:45am 11:55am	Symposium 5C Partnering for Prevention : AMS strengthening IPC Dr.Nor Zaila binti Zaidan Chairperson Hospital KajangMalaysia Dr.Syamhanin Adnan Chairperson MOH (Hospital Sungai Buloh)Malaysia Building Resilient IPC Programs Through Sustainable AMS Implementation Dr.Rahela Ambaras Khan Speaker Hospital Kuala LumpurMalaysia Strengthening IPC Through AMS: Regional Perspectives on Antibiotic Stewardship Assoc. Prof.Andrea Kwa Speaker Singapore General HospitalSingapore Leveraging Data and Digital Tools: Driving AMS to Prevent Infections Prof.Karin Thursky Speaker University of MelbourneAustralia Q&A Conference Hall 3
4:20pm 5:30pm	Symposium 7C Bacteriophage Therapy in Infection Control: From Concept to Clinical Application Dr.Tan Seow Yen Chairperson Changi General HospitalSingapore Phage therapy : Past, present and future Dr.Jasmine Chung Speaker Singapore General HospitalSingapore Challenges of Phage Research in Singapore Assoc. Prof.Andrea Kwa Speaker Singapore General HospitalSingapore Case for Adjunctive Bacteriophage Therapy for Difficult-to-treat Infections Dr.Jasmine Chung Speaker Singapore General HospitalSingapore Q&A Conference Hall 3